Acumen Pharmaceuticals, Inc.

Q: Jun 30 2026

Q: Mar 31 2026

FY: Dec 31 2025

Q: Sep 30 2025

Q: Jun 30 2025

Q: Mar 31 2025

FY: Dec 31 2024

Q: Sep 30 2024

Q: Jun 30 2024

Q: Mar 31 2024

FY: Dec 31 2023

Q: Sep 30 2023

Q: Jun 30 2023

Q: Mar 31 2023

FY: Dec 31 2022

Q: Sep 30 2022

Q: Jun 30 2022

Q: Mar 31 2022

FY: Dec 31 2021

Q: Sep 30 2021

Regulation FD Disclosure

Results of Operations and Financial Condition

Regulation FD Disclosure

Submission of Matters to a Vote of Security Holders

Results of Operations and Financial Condition

Results of Operations and Financial Condition

Entry into a Material Definitive Agreement

Regulation FD Disclosure

Results of Operations and Financial Condition

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Results of Operations and Financial Condition

Entry into a Material Definitive Agreement

Submission of Matters to a Vote of Security Holders

Results of Operations and Financial Condition

Results of Operations and Financial Condition

2.02,7.01,9.01

2.02,7.01,9.01

5.07

2.02,7.01,9.01

2.02,9.01

Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans

Notice of Effectiveness

Prospectus Supplement for Primary Offering

Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans

Registration statement under Securities Act of 1933

Prospectus Supplement for Primary Offering

Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans

Notice of Effectiveness

Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans

Registration statement under Securities Act of 1933

Prospectus Supplement for Primary Offering

Prospectus Supplement for Primary Offering

Prospectus Supplement for Primary Offering

Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans

Notice of Effectiveness

Registration statement under Securities Act of 1933

Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans

Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans

Prospectus Supplement with Pricing Information

No description available

Definitive Proxy Statement

Additional Information for Proxy Statement/ Votes

Additional Information for Proxy Statement/ Votes

Definitive Proxy Statement

Additional Information for Proxy Statement/ Votes

Definitive Proxy Statement

Additional Information for Proxy Statement/ Votes

Definitive Proxy Statement

Preliminary Proxy Statement

Definitive Proxy Statement

Additional Information for Proxy Statement/ Votes

Porter Derrell

Porter Derrell

Porter Derrell

Porter Derrell

Fountain Nathan B

Fountain Nathan B

Stalfort John A III

RA Capital Healthcare Fund LP; RA CAPITAL MANAGEMENT, L.P.; RA Capital Nexus Fund II, L.P.; Kolchinsky Peter; Shah Rajeev M.

Fountain Nathan B

Drapkin Kimberlee C

Golumbeski George

Porter Derrell

Ives Jeffrey L.

Stoppel Laura

MURRAY JAMES B JR

RA Capital Healthcare Fund LP; RA CAPITAL MANAGEMENT, L.P.; RA Capital Nexus Fund II, L.P.; Kolchinsky Peter; Shah Rajeev M.

RA CAPITAL MANAGEMENT, L.P.

Meisner Derek M

Meisner Derek M

Meisner Derek M

Annual Report Scanned (Paper)

Letter from the SEC

Correspondence with the SEC

Annual Report Scanned (Paper)

Annual Report Scanned (Paper)

Correspondence with the SEC

Letter from the SEC

Annual Report Scanned (Paper)

Letter from the SEC

Correspondence with the SEC

No description available

Correspondence with the SEC

Correspondence with the SEC

Correspondence with the SEC

Correspondence with the SEC

Letter from the SEC

Correspondence with the SEC

No description available

Draft registration statement (confidential submission) (amendment)

Letter from the SEC